Stay updated on Pembrolizumab+Bevacizumab+Cyclophosphamide in Recurrent Ovarian Ca Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Bevacizumab+Cyclophosphamide in Recurrent Ovarian Ca Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Bevacizumab+Cyclophosphamide in Recurrent Ovarian Ca Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Updated page revision label to v3.3.4 and removed the previous v3.3.3 label. This metadata update does not alter study details, eligibility criteria, or results.
    Difference
    0.0%
    Check dated 2026-01-14T03:13:04.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Added a Locations section featuring New York as a study location. Page revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T21:04:52.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    The Publications section now states that entries are automatically filled from PubMed and may not be about the study, with revision updated to v3.3.2. The older PubMed description and revision v3.2.0 were removed.
    Difference
    0.1%
    Check dated 2025-11-25T10:47:44.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Removed the site-wide notice about government funding delays; no study content or core details (such as eligibility, outcomes, or locations) are affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-18T06:55:35.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    The screenshots show only minor formatting/layout adjustments with no changes to core study details such as objectives, eligibility criteria, interventions, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T21:07:54.000Z thumbnail image
  8. Check
    102 days ago
    Change Detected
    Summary
    Key updates: version bump to v3.2.0 and the addition of an up-to-date operating status notice (including NIH Clinical Center status and links). Deletion of the previous version tag v3.1.0. overall, indicates a maintenance refresh with updated operating status information.
    Difference
    2%
    Check dated 2025-10-06T05:36:45.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Bevacizumab+Cyclophosphamide in Recurrent Ovarian Ca Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Bevacizumab+Cyclophosphamide in Recurrent Ovarian Ca Clinical Trial page.